Bonus BioGroup Ltd. (TLV:BONS)
41.70
-0.80 (-1.88%)
Apr 29, 2026, 5:24 PM IDT
Bonus BioGroup Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0.23 | 6.86 | 12.94 | 53.62 | 79.55 | Upgrade
|
| Short-Term Investments | - | - | 13.04 | - | - | Upgrade
|
| Cash & Short-Term Investments | 0.23 | 6.86 | 25.98 | 53.62 | 79.55 | Upgrade
|
| Cash Growth | -96.68% | -73.59% | -51.56% | -32.59% | 394.53% | Upgrade
|
| Other Receivables | 0.62 | 0.09 | 0.25 | 0.51 | 1.16 | Upgrade
|
| Receivables | 0.62 | 0.09 | 0.25 | 0.51 | 1.16 | Upgrade
|
| Prepaid Expenses | 0.9 | 0.24 | 0.21 | 0.31 | 0.3 | Upgrade
|
| Total Current Assets | 1.75 | 7.19 | 26.44 | 54.43 | 81 | Upgrade
|
| Property, Plant & Equipment | 13.31 | 15.83 | 18.05 | 19.77 | 14.96 | Upgrade
|
| Long-Term Investments | - | - | - | - | 7.9 | Upgrade
|
| Other Intangible Assets | - | 0.01 | 0.02 | 0.04 | - | Upgrade
|
| Other Long-Term Assets | 0.38 | 0.38 | 0.37 | 0.37 | 0.46 | Upgrade
|
| Total Assets | 15.44 | 23.41 | 44.89 | 74.61 | 104.32 | Upgrade
|
| Accounts Payable | 1.84 | 1.01 | 1.41 | 1.95 | 3.99 | Upgrade
|
| Accrued Expenses | 2.22 | 2 | 2.21 | 2.98 | 2.43 | Upgrade
|
| Current Portion of Leases | 1.79 | 1.66 | 1.48 | 1.35 | 1.23 | Upgrade
|
| Other Current Liabilities | 8.15 | 3.25 | 0.81 | 1.34 | 1.12 | Upgrade
|
| Total Current Liabilities | 13.99 | 7.92 | 5.91 | 7.62 | 8.77 | Upgrade
|
| Long-Term Leases | 7.11 | 8.53 | 9.67 | 10.6 | 11.12 | Upgrade
|
| Total Liabilities | 21.11 | 16.45 | 15.58 | 18.22 | 19.89 | Upgrade
|
| Common Stock | 306.47 | 303.32 | 302.66 | 300.79 | 296.52 | Upgrade
|
| Retained Earnings | -362.09 | -337.6 | -309.78 | -281.25 | -242.55 | Upgrade
|
| Comprehensive Income & Other | 49.96 | 41.25 | 36.42 | 36.85 | 30.45 | Upgrade
|
| Shareholders' Equity | -5.66 | 6.96 | 29.31 | 56.39 | 84.43 | Upgrade
|
| Total Liabilities & Equity | 15.44 | 23.41 | 44.89 | 74.61 | 104.32 | Upgrade
|
| Total Debt | 8.9 | 10.19 | 11.16 | 11.95 | 12.35 | Upgrade
|
| Net Cash (Debt) | -8.67 | -3.33 | 14.82 | 41.67 | 67.2 | Upgrade
|
| Net Cash Growth | - | - | -64.44% | -37.99% | 514.71% | Upgrade
|
| Net Cash Per Share | -0.01 | -0.00 | 0.01 | 0.04 | 0.06 | Upgrade
|
| Filing Date Shares Outstanding | 1,168 | 1,168 | 1,168 | 1,168 | 1,154 | Upgrade
|
| Total Common Shares Outstanding | 1,168 | 1,168 | 1,168 | 1,168 | 1,154 | Upgrade
|
| Working Capital | -12.24 | -0.73 | 20.53 | 46.81 | 72.23 | Upgrade
|
| Book Value Per Share | -0.00 | 0.01 | 0.03 | 0.05 | 0.07 | Upgrade
|
| Tangible Book Value | -5.66 | 6.95 | 29.28 | 56.35 | 84.43 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | 0.01 | 0.03 | 0.05 | 0.07 | Upgrade
|
| Machinery | 3.68 | 4.35 | 4.25 | 4.05 | 0.8 | Upgrade
|
| Leasehold Improvements | 8.24 | 8.45 | 8.44 | 8.25 | 4.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.